id,name,Component,Uuid,age,ageUnit,aliquotID,assay,cellType,comments,dataSubtype,dataType,diagnosis,dissociationMethod,entityId,experimentalCondition,experimentalTimepoint,fileFormat,fundingAgency,individualID,initiative,isCellLine,isMultiIndividual,isMultiSpecimen,isPrimaryCell,libraryPrep,libraryPreparationMethod,modelSystemName,nf1Genotype,nf2Genotype,nucleicAcidSource,organ,parentSpecimenID,platform,progressReportNumber,readPair,resourceType,sex,species,specimenID,specimenPreparationMethod,studyId,studyName,timePointUnit,tissue,tumorType
syn22762051,NF0002-8-19--D-plus-C_S46_L003_R2_001.fastq.gz,EpigeneticsAssayTemplate,942e0499-b45f-498e-b0ea-5480483b7696,41,NA,NA,bisulfite sequencing,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762051,"Cytokines,DMEM",NA,fastq,NTAP,NF0007,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0007-4-M,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762052,NF0002-8-19--D-plus-C_S46_L003_R1_001.fastq.gz,EpigeneticsAssayTemplate,dc548f30-ecd4-46bf-b2e7-9426293ccff8,41,NA,NA,bisulfite sequencing,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762052,"Cytokines,DMEM",NA,fastq,NTAP,NF0007,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0007-4-M,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762205,NF0002-8-19--M--Mammo_S42_L003_R2_001.fastq.gz,EpigeneticsAssayTemplate,638392b5-14ed-4069-84bd-71d99df8e7c1,41,NA,NA,bisulfite sequencing,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762205,Mammo,NA,fastq,NTAP,NF0007,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0007-4 S,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762207,NF0002-8-19--D--DMEM_S45_L003_R2_001.fastq.gz,EpigeneticsAssayTemplate,2b8cc4d7-09d7-4df7-a63f-552098981182,41,NA,NA,bisulfite sequencing,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762207,DMEM,NA,fastq,NTAP,NF0007,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0007-4 S,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762213,NF0002-8-19--M--Mammo_S42_L003_R1_001.fastq.gz,EpigeneticsAssayTemplate,52145c97-1798-4b64-91ed-0ee22923e54e,41,NA,NA,bisulfite sequencing,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762213,Mammo,NA,fastq,NTAP,NF0007,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0007-4-S+C+F,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762228,NF0002-8-19--D-plus-C-plus-F_S47_L003_R2_001.fastq.gz,EpigeneticsAssayTemplate,654d31f6-64d1-4c6e-b255-a976f0d5e061,41,NA,NA,bisulfite sequencing,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762228,"Cytokines,DMEM,Forskoline",NA,fastq,NTAP,NF0007,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0007-4-S+C+F,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762229,NF0002-8-19--M-plus-C-plus-F_S44_L003_R2_001.fastq.gz,EpigeneticsAssayTemplate,38861968-57ea-4921-8441-b3a0b2752dc0,41,NA,NA,bisulfite sequencing,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762229,"Cytokines,Forskoline,Mammo",NA,fastq,NTAP,NF0007,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0007-4-S+C,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762231,NF0002-8-19--M-plus-C-plus-F_S44_L003_R1_001.fastq.gz,EpigeneticsAssayTemplate,60569ed6-7f9b-4a20-9a3f-a0044c979f8f,41,NA,NA,bisulfite sequencing,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762231,"Cytokines,Forskoline,Mammo",NA,fastq,NTAP,NF0007,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0007-4-S+C,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762235,NF0002-8-19--D--DMEM_S45_L003_R1_001.fastq.gz,EpigeneticsAssayTemplate,4e09fda0-546c-4e5f-b1cb-772c536d246e,41,NA,NA,bisulfite sequencing,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762235,DMEM,NA,fastq,NTAP,NF0007,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0007-2-M+C+F,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762236,NF0002-8-19--M-plus-C_S43_L003_R2_001.fastq.gz,EpigeneticsAssayTemplate,96ce6e2a-1775-47ee-a193-bef14710f20c,41,NA,NA,bisulfite sequencing,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762236,"Cytokines,Mammo",NA,fastq,NTAP,NF0007,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0007-4,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762241,NF0002-8-19--D-plus-C-plus-F_S47_L003_R1_001.fastq.gz,EpigeneticsAssayTemplate,9a94a153-cbae-418a-b143-999c831a3e67,41,NA,NA,bisulfite sequencing,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762241,"Cytokines,DMEM,Forskoline",NA,fastq,NTAP,NF0007,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0007-2-M+C+F,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762243,NF0002-8-19--M-plus-C_S43_L003_R1_001.fastq.gz,EpigeneticsAssayTemplate,bd3fb52b-ed92-41e5-bb51-cb22353a3141,41,NA,NA,bisulfite sequencing,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762243,"Cytokines,Mammo",NA,fastq,NTAP,NF0007,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0007-4,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762283,NF0002-8-19--S-plus-C_S49_L003_R2_001.fastq.gz,EpigeneticsAssayTemplate,9445fe9b-aed4-407b-92e2-9716be97a028,39,NA,NA,bisulfite sequencing,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762283,"Cytokines,StemPro",NA,fastq,NTAP,NF0008,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0008-1-D+C+F,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762293,NF0002-8-19--S-plus-C_S49_L003_R1_001.fastq.gz,EpigeneticsAssayTemplate,7773a8da-d073-42ba-8da0-8684f04f8027,39,NA,NA,bisulfite sequencing,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762293,"Cytokines,StemPro",NA,fastq,NTAP,NF0008,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0008-1-D+C+F,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762295,NF0002-8-19--S-plus-C-plus-F_S50_L003_R2_001.fastq.gz,EpigeneticsAssayTemplate,1521718e-d797-474b-8abe-2a88cd2adcb1,39,NA,NA,bisulfite sequencing,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762295,"Cytokines,Forskoline,StemPro",NA,fastq,NTAP,NF0008,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0008-1-D+C,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762299,NF0002-8-19--S-plus-C-plus-F_S50_L003_R1_001.fastq.gz,EpigeneticsAssayTemplate,42beba35-4759-47e2-8ab9-fade985c5995,39,NA,NA,bisulfite sequencing,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762299,"Cytokines,Forskoline,StemPro",NA,fastq,NTAP,NF0008,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0008-1-M,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762300,NF0002-8-19_S5_L001_R1_001.fastq.gz,EpigeneticsAssayTemplate,d0cadf94-af1b-425c-893b-a493d848d698,39,NA,NA,bisulfite sequencing,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762300,NA,NA,fastq,NTAP,NF0008,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0008-1-M,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762303,NF0002-8-19_S5_L001_R2_001.fastq.gz,EpigeneticsAssayTemplate,3be6231d-e6a7-48b5-9bb5-c3243760ec52,39,NA,NA,bisulfite sequencing,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762303,NA,NA,fastq,NTAP,NF0008,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0008-1 D,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762324,NF0007-2--D-plus-C_S10_L001_R1_001.fastq.gz,EpigeneticsAssayTemplate,f080d1d7-6e8a-4a1f-bc04-f9ea7499cc18,39,NA,NA,bisulfite sequencing,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762324,"Cytokines,DMEM",NA,fastq,NTAP,NF0008,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0008-1 D,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762332,NF0007-2--D-plus-C_S10_L001_R2_001.fastq.gz,EpigeneticsAssayTemplate,3f09c816-87c3-431d-8226-13297ef3c9c4,39,NA,NA,bisulfite sequencing,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762332,"Cytokines,DMEM",NA,fastq,NTAP,NF0008,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0008-1-D+C,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762349,NF0007-2--D--DMEM_S9_L001_R1_001.fastq.gz,EpigeneticsAssayTemplate,57c15326-7036-4477-a61f-89358bbeb873,39,NA,NA,bisulfite sequencing,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762349,DMEM,NA,fastq,NTAP,NF0008,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0008-1-M+C+F,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762351,NF0007-2--D--DMEM_S9_L001_R2_001.fastq.gz,EpigeneticsAssayTemplate,3b3ef6ed-3672-49ab-bc4f-0dc12936b1cb,39,NA,NA,bisulfite sequencing,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762351,DMEM,NA,fastq,NTAP,NF0008,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0008-1-M+C+F,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762377,NF0007-2--D-plus-C-plus-F_S11_L001_R2_001.fastq.gz,EpigeneticsAssayTemplate,992eb333-5783-4c61-9843-8a7f5cd38b55,39,NA,NA,bisulfite sequencing,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762377,"Cytokines,DMEM,Forskoline",NA,fastq,NTAP,NF0008,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0008-1 S,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762381,NF0007-2--D-plus-C-plus-F_S11_L001_R1_001.fastq.gz,EpigeneticsAssayTemplate,49b38877-7295-4b42-ae54-b0f302cb39b3,39,NA,NA,bisulfite sequencing,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762381,"Cytokines,DMEM,Forskoline",NA,fastq,NTAP,NF0008,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0008-1 S,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762382,NF0007-2--S--StemPro_S12_L001_R1_001.fastq.gz,EpigeneticsAssayTemplate,ad21af2e-4790-48f0-9368-d5049b71e783,39,NA,NA,bisulfite sequencing,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762382,StemPro,NA,fastq,NTAP,NF0008,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0008-1-M+C,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762386,NF0007-2--S-plus-C-plus-F_S14_L001_R1_001.fastq.gz,EpigeneticsAssayTemplate,281224f3-a085-4074-90fc-5d61101015dd,39,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762386,"Cytokines,Forskoline,StemPro",NA,fastq,NTAP,NF0008,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0008-1-M+C,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762392,NF0007-2--S--StemPro_S12_L001_R2_001.fastq.gz,EpigeneticsAssayTemplate,398da4ed-094d-4ed5-b852-ff4c9d16bbc4,39,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762392,StemPro,NA,fastq,NTAP,NF0008,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0008-1-S+C+F,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762404,NF0007-2--S-plus-C-plus-F_S14_L001_R2_001.fastq.gz,EpigeneticsAssayTemplate,bc649c0f-5490-4733-803c-d31e0247d2e7,39,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762404,"Cytokines,Forskoline,StemPro",NA,fastq,NTAP,NF0008,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0008-1-S+C+F,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762416,NF0007-2-M--Mammo_S6_L001_R1_001.fastq.gz,EpigeneticsAssayTemplate,27dda0ae-4e8b-4ef7-a283-935692da8d20,39,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762416,Mammo,NA,fastq,NTAP,NF0008,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0008-1-S+C,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762417,NF0007-2-M--Mammo_S6_L001_R2_001.fastq.gz,EpigeneticsAssayTemplate,c0fee372-6f65-4bf7-93bb-96121bcb8753,39,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762417,Mammo,NA,fastq,NTAP,NF0008,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0008-1-S+C,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762440,NF0007-2--S-plus-C_S13_L001_R1_001.fastq.gz,EpigeneticsAssayTemplate,71e5443d-e5fd-45f8-8233-63446392f7c0,29,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762440,"Cytokines,StemPro",NA,fastq,NTAP,NF0009,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0009-1-D+C+F,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762448,NF0007-2--S-plus-C_S13_L001_R2_001.fastq.gz,EpigeneticsAssayTemplate,909ddc41-950d-4c44-8bbe-29d306988821,39,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762448,"Cytokines,StemPro",NA,fastq,NTAP,NF0008,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0008-1,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762500,NF0007-2-M-plus-C_S7_L001_R2_001.fastq.gz,EpigeneticsAssayTemplate,63f30312-a2bb-470f-a771-de100a42b0bc,29,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762500,"Cytokines,Mammo",NA,fastq,NTAP,NF0009,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0009-1-D+C+F,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762501,NF0007-2-M-plus-C_S7_L001_R1_001.fastq.gz,EpigeneticsAssayTemplate,172e871e-cc86-4202-9442-6446dd812349,39,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762501,"Cytokines,Mammo",NA,fastq,NTAP,NF0008,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0008-1,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762515,NF0007-2_S1_L001_R2_001.fastq.gz,EpigeneticsAssayTemplate,bed35a7d-191b-4624-82aa-24071ea13ee4,29,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762515,NA,NA,fastq,NTAP,NF0009,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0009-1 D,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762537,NF0007-2_S1_L001_R1_001.fastq.gz,EpigeneticsAssayTemplate,2e391d19-145e-4149-a999-40f647d89c88,29,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762537,NA,NA,fastq,NTAP,NF0009,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0009-1 D,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762572,NF0007-4--D--DMEM_S18_L001_R2_001.fastq.gz,EpigeneticsAssayTemplate,71d9233e-1cc6-4d27-8197-0ecf0ae11540,29,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762572,DMEM,NA,fastq,NTAP,NF0009,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0009-1-D+C,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762580,NF0007-4--D--DMEM_S18_L001_R1_001.fastq.gz,EpigeneticsAssayTemplate,55ae9ef6-fff7-4983-aa0c-b3f76c8fab36,29,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762580,DMEM,NA,fastq,NTAP,NF0009,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0009-1-D+C,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762591,NF0002-8-19--S--StemPro_S48_L003_R1_001.fastq.gz,EpigeneticsAssayTemplate,47704d88-117f-4788-9c7c-5c41d01afb29,29,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762591,StemPro,NA,fastq,NTAP,NF0009,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0009-1 M,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762608,NF0007-4--D-plus-C-plus-F_S20_L001_R2_001.fastq.gz,EpigeneticsAssayTemplate,3928415f-c453-4434-8ab7-d2610f600ba7,29,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762608,"Cytokines,DMEM,Forskoline",NA,fastq,NTAP,NF0009,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0009-1 M,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762613,NF0007-4--D-plus-C-plus-F_S20_L001_R1_001.fastq.gz,EpigeneticsAssayTemplate,f333ff43-5ebf-46e1-9bd6-7d268d4f2924,29,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762613,"Cytokines,DMEM,Forskoline",NA,fastq,NTAP,NF0009,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0009-1-M+C+F,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762630,NF0007-4--D-plus-C_S19_L001_R1_001.fastq.gz,EpigeneticsAssayTemplate,1b5b7b76-6a55-4678-8ef9-8caed1db7d55,29,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762630,"Cytokines,DMEM",NA,fastq,NTAP,NF0009,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0009-1-M+C+F,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762634,NF0007-4--D-plus-C_S19_L001_R2_001.fastq.gz,EpigeneticsAssayTemplate,fb94b173-ccb5-4601-8f74-18b75902f1c3,29,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762634,"Cytokines,DMEM",NA,fastq,NTAP,NF0009,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0009-1-S+C+F,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762650,NF0002-8-19--S--StemPro_S48_L003_R2_001.fastq.gz,EpigeneticsAssayTemplate,e3999411-4b0d-46c3-8f84-1050cce752f8,29,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762650,StemPro,NA,fastq,NTAP,NF0009,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0009-1-M+C,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762674,NF0007-4--M-plus-C-plus-F_S17_L001_R1_001.fastq.gz,EpigeneticsAssayTemplate,528b9cc3-a70a-4f5b-ab19-b2ccec5845ab,29,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762674,"Cytokines,Forskoline,Mammo",NA,fastq,NTAP,NF0009,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0009-1-M+C,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762690,NF0007-4--M-plus-C-plus-F_S17_L001_R2_001.fastq.gz,EpigeneticsAssayTemplate,5e093e43-0169-4bac-9ce2-1b210d60a7bd,29,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762690,"Cytokines,Forskoline,Mammo",NA,fastq,NTAP,NF0009,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0009-1-S+C+F,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762693,NF0007-4--M-plus-C_S16_L001_R1_001.fastq.gz,EpigeneticsAssayTemplate,5c790fae-a14e-4dd9-84e3-50890b8aee6b,29,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762693,"Cytokines,Mammo",NA,fastq,NTAP,NF0009,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0009-1-S+C,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762696,NF0007-4--M-plus-C_S16_L001_R2_001.fastq.gz,EpigeneticsAssayTemplate,8851e407-1c80-40d8-b5a2-f7a171f4638b,29,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762696,"Cytokines,Mammo",NA,fastq,NTAP,NF0009,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0009-1-S+C,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762712,NF0007-4--M--Mammo_S15_L001_R2_001.fastq.gz,EpigeneticsAssayTemplate,39d8e1c7-61cb-4aec-b482-3a8abaa645c7,29,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762712,Mammo,NA,fastq,NTAP,NF0009,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0009-1,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762720,NF0007-4--M--Mammo_S15_L001_R1_001.fastq.gz,EpigeneticsAssayTemplate,0b8b53eb-9823-44e8-9c34-beb19600e2cd,29,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762720,Mammo,NA,fastq,NTAP,NF0009,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0009-1,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762734,NF0007-4--S--StemPro_S21_L002_R1_001.fastq.gz,EpigeneticsAssayTemplate,574f827a-4e06-4386-8373-bffd54c2b4b4,29,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762734,StemPro,NA,fastq,NTAP,NF0009,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0009-1 S,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762742,NF0007-4--S--StemPro_S21_L002_R2_001.fastq.gz,EpigeneticsAssayTemplate,3e31b92b-c413-4732-9dee-3112b79ea765,59,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762742,StemPro,NA,fastq,NTAP,NF0012,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Male,Homo sapiens,NF0012-3-6 D,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762755,NF0007-4--S-plus-C-plus-F_S23_L002_R1_001.fastq.gz,EpigeneticsAssayTemplate,885adda3-ea30-4ee2-87c0-ba71afae3daf,29,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762755,"Cytokines,Forskoline,StemPro",NA,fastq,NTAP,NF0009,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0009-1 S,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762760,NF0007-4--S-plus-C-plus-F_S23_L002_R2_001.fastq.gz,EpigeneticsAssayTemplate,eef94383-7117-4126-9046-591209e7968a,59,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762760,"Cytokines,Forskoline,StemPro",NA,fastq,NTAP,NF0012,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Male,Homo sapiens,NF0012-3-6 D,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762767,NF0007-4--S-plus-C_S22_L002_R2_001.fastq.gz,EpigeneticsAssayTemplate,6b07d4cc-218f-499a-9d7a-559cb9e74b2f,59,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762767,"Cytokines,StemPro",NA,fastq,NTAP,NF0012,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Male,Homo sapiens,NF0012-3-6-D+C+F,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762771,NF0007-4--S-plus-C_S22_L002_R1_001.fastq.gz,EpigeneticsAssayTemplate,cb1ea001-efee-4bd5-add8-86605c35c45b,59,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762771,"Cytokines,StemPro",NA,fastq,NTAP,NF0012,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Male,Homo sapiens,NF0012-3-6-D+C+F,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762790,NF0007-2-M-plus-C-plus-F_S8_L001_R1_001.fastq.gz,EpigeneticsAssayTemplate,5553a092-c4be-4e6b-8ebd-478e9734076b,59,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762790,"Cytokines,Forskoline,Mammo",NA,fastq,NTAP,NF0012,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Male,Homo sapiens,NF0012-3-6 M,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762791,NF0007-4_S2_L001_R2_001.fastq.gz,EpigeneticsAssayTemplate,85a68a9e-f619-4bc7-8607-c1702aee1601,59,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762791,NA,NA,fastq,NTAP,NF0012,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Male,Homo sapiens,NF0012-3-6 M,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762798,NF0007-2-M-plus-C-plus-F_S8_L001_R2_001.fastq.gz,EpigeneticsAssayTemplate,07e68f6d-92bc-435c-bbd0-1d57f72f2d6b,59,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762798,"Cytokines,Forskoline,Mammo",NA,fastq,NTAP,NF0012,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Male,Homo sapiens,NF0012-3-6-D+C,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762801,NF0007-4_S2_L001_R1_001.fastq.gz,EpigeneticsAssayTemplate,4a0a3650-28ff-4bb0-902e-fcce82c38d32,59,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762801,NA,NA,fastq,NTAP,NF0012,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Male,Homo sapiens,NF0012-3-6-M+C+F,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762825,NF0008-1--D-plus-C-plus-F_S57_L003_R2_001.fastq.gz,EpigeneticsAssayTemplate,d251d63a-3416-4c6b-87f0-021794035ba1,59,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762825,"Cytokines,DMEM,Forskoline",NA,fastq,NTAP,NF0012,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Male,Homo sapiens,NF0012-3-6-M+C+F,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762827,NF0008-1--D-plus-C-plus-F_S57_L003_R1_001.fastq.gz,EpigeneticsAssayTemplate,9f721fb0-10d2-4a9f-884f-dbdc51fa5243,59,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762827,"Cytokines,DMEM,Forskoline",NA,fastq,NTAP,NF0012,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Male,Homo sapiens,NF0012-3-6-M+C,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762837,NF0008-1--D-plus-C_S56_L003_R2_001.fastq.gz,EpigeneticsAssayTemplate,2cb30b61-524b-477c-974e-66788c2a70d4,59,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762837,"Cytokines,DMEM",NA,fastq,NTAP,NF0012,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Male,Homo sapiens,NF0012-3-6-D+C,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762844,NF0008-1--M--Mammo_S52_L003_R1_001.fastq.gz,EpigeneticsAssayTemplate,74491af1-116d-48e4-a70d-1deadad44855,59,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762844,Mammo,NA,fastq,NTAP,NF0012,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Male,Homo sapiens,NF0012-3-6-M+C,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762847,NF0008-1--M--Mammo_S52_L003_R2_001.fastq.gz,EpigeneticsAssayTemplate,42155157-52b7-499d-a651-3d1d918d4e53,59,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762847,Mammo,NA,fastq,NTAP,NF0012,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Male,Homo sapiens,NF0012-3-6 S,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762850,NF0008-1--D--DMEM_S55_L003_R2_001.fastq.gz,EpigeneticsAssayTemplate,2f7313c5-b05d-44c9-be85-458d99e1144e,59,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762850,DMEM,NA,fastq,NTAP,NF0012,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Male,Homo sapiens,NF0012-3-6 S,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762858,NF0008-1--D--DMEM_S55_L003_R1_001.fastq.gz,EpigeneticsAssayTemplate,b990a598-7ea8-445d-b05f-d3689dd11311,59,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762858,DMEM,NA,fastq,NTAP,NF0012,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Male,Homo sapiens,NF0012-3-6-S+C,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762860,NF0008-1--D-plus-C_S56_L003_R1_001.fastq.gz,EpigeneticsAssayTemplate,244b9f51-dd59-4210-94b6-4c7ff289c361,59,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762860,"Cytokines,DMEM",NA,fastq,NTAP,NF0012,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Male,Homo sapiens,NF0012-3-6,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762882,NF0008-1--M-plus-C-plus-F_S54_L003_R1_001.fastq.gz,EpigeneticsAssayTemplate,be47d4a1-fdbe-44fb-aea6-95ff309b51d9,59,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762882,"Cytokines,Forskoline,Mammo",NA,fastq,NTAP,NF0012,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Male,Homo sapiens,NF0012-3-6-S+C,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762883,NF0008-1--M-plus-C-plus-F_S54_L003_R2_001.fastq.gz,EpigeneticsAssayTemplate,8f95d4e9-85b0-405c-8677-12adcd3ed9b3,59,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762883,"Cytokines,Forskoline,Mammo",NA,fastq,NTAP,NF0012,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Male,Homo sapiens,NF0012-3-6,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762896,NF0008-1--S--StemPro_S58_L003_R2_001.fastq.gz,EpigeneticsAssayTemplate,981ebeca-1a58-47ee-979d-f768f50462a8,59,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762896,StemPro,NA,fastq,NTAP,NF0012,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Male,Homo sapiens,NF0012-3-6-S+C+F,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762899,NF0008-1--S--StemPro_S58_L003_R1_001.fastq.gz,EpigeneticsAssayTemplate,75b251c5-f610-49f5-aae9-d1dd198a13b5,59,NA,NA,bisulfiteSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762899,StemPro,NA,fastq,NTAP,NF0012,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Male,Homo sapiens,NF0012-3-6-S+C+F,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762917,NF0008-1--M-plus-C_S53_L003_R2_001.fastq.gz,EpigeneticsAssayTemplate,aa556efc-62a5-475c-9f56-cce87cb9ea1a,29,NA,NA,RNA-seq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762917,"Cytokines,Mammo",NA,fastq,NTAP,NF0009,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0009-1,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762919,NF0008-1--M-plus-C_S53_L003_R1_001.fastq.gz,EpigeneticsAssayTemplate,1a9f5cdc-ff25-4fa9-ad24-847779ff0413,29,NA,NA,RNA-seq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762919,"Cytokines,Mammo",NA,fastq,NTAP,NF0009,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0009-1 D,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762935,NF0008-1--S-plus-C-plus-F_S60_L003_R1_001.fastq.gz,EpigeneticsAssayTemplate,d11e922e-448f-42fd-bf6a-a2d7f61f1680,29,NA,NA,RNA-seq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762935,"Cytokines,Forskoline,StemPro",NA,fastq,NTAP,NF0009,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0009-1 M,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762937,NF0008-1--S-plus-C-plus-F_S60_L003_R2_001.fastq.gz,EpigeneticsAssayTemplate,1732002b-fcea-48f2-a349-4dfc48819f46,29,NA,NA,rnaSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762937,"Cytokines,Forskoline,StemPro",NA,fastq,NTAP,NF0009,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0009-1 S,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762946,NF0008-1--S-plus-C_S59_L003_R1_001.fastq.gz,EpigeneticsAssayTemplate,d158aedb-d3b0-4a1f-b2e2-82b201f6123b,29,NA,NA,rnaSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762946,"Cytokines,StemPro",NA,fastq,NTAP,NF0009,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0009-1-D+C,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762947,NF0008-1--S-plus-C_S59_L003_R2_001.fastq.gz,EpigeneticsAssayTemplate,401796f3-3ddc-4943-b0a3-2cbf34a1719d,29,NA,NA,RNA-seq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762947,"Cytokines,StemPro",NA,fastq,NTAP,NF0009,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0009-1-D+C+F,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762967,NF0009-1--D-plus-C-plus-F_S38_L002_R1_001.fastq.gz,EpigeneticsAssayTemplate,538fb6fb-d395-49c6-9071-1f6b4ea3d980,29,NA,NA,RNA-seq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762967,"Cytokines,DMEM,Forskoline",NA,fastq,NTAP,NF0009,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0009-1-M+C,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762968,NF0008-1_S51_L003_R2_001.fastq.gz,EpigeneticsAssayTemplate,3ac5ea5d-e473-4ecd-a1d8-e01863191eba,29,NA,NA,RNA-seq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762968,NA,NA,fastq,NTAP,NF0009,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0009-1-M+C+F,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762971,NF0009-1--D-plus-C-plus-F_S38_L002_R2_001.fastq.gz,EpigeneticsAssayTemplate,b4a2b3cf-3be0-4415-b363-5c6055f4bfef,29,NA,NA,RNA-seq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762971,"Cytokines,DMEM,Forskoline",NA,fastq,NTAP,NF0009,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0009-1-S+C,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762976,NF0008-1_S51_L003_R1_001.fastq.gz,EpigeneticsAssayTemplate,3e84d422-45b4-4748-8036-7a923b848ca3,29,NA,NA,RNA-seq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762976,NA,NA,fastq,NTAP,NF0009,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0009-1-S+C+F,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22762995,NF0009-1--D--DMEM_S36_L002_R2_001.fastq.gz,EpigeneticsAssayTemplate,bebbfd55-ca0d-48e1-b643-cfaecdf8e91e,59,NA,NA,RNA-seq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22762995,DMEM,NA,fastq,NTAP,NF0012,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Male,Homo sapiens,NF0012-3-6,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763004,NF0009-1--D--DMEM_S36_L002_R1_001.fastq.gz,EpigeneticsAssayTemplate,c7f538db-735f-49e1-93a9-319bd22185c8,59,NA,NA,RNA-seq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763004,DMEM,NA,fastq,NTAP,NF0012,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Male,Homo sapiens,NF0012-3-6 D,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763023,NF0009-1--D-plus-C_S37_L002_R2_001.fastq.gz,EpigeneticsAssayTemplate,9ae7eccd-263c-44fa-9b05-cfac25f86795,59,NA,NA,RNA-seq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763023,"Cytokines,DMEM",NA,fastq,NTAP,NF0012,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Male,Homo sapiens,NF0012-3-6 M,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763032,NF0009-1--D-plus-C_S37_L002_R1_001.fastq.gz,EpigeneticsAssayTemplate,08efbddd-8039-49b1-b9f0-655c1e363179,59,NA,NA,RNA-seq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763032,"Cytokines,DMEM",NA,fastq,NTAP,NF0012,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Male,Homo sapiens,NF0012-3-6 S,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763036,NF0009-1--M--Mammo_S33_L002_R2_001.fastq.gz,EpigeneticsAssayTemplate,4ec5addd-6371-4498-a50d-be27face09f2,59,NA,NA,RNA-seq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763036,Mammo,NA,fastq,NTAP,NF0012,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Male,Homo sapiens,NF0012-3-6-D+C,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763041,NF0009-1--M--Mammo_S33_L002_R1_001.fastq.gz,EpigeneticsAssayTemplate,7b28c659-9b4f-4a86-89a9-bd0e026e9535,59,NA,NA,RNA-seq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763041,Mammo,NA,fastq,NTAP,NF0012,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Male,Homo sapiens,NF0012-3-6-D+C+F,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763047,NF0009-1--M-plus-C-plus-F_S35_L002_R2_001.fastq.gz,EpigeneticsAssayTemplate,77c9a2be-7cbb-4270-b477-8fbbd371485d,59,NA,NA,RNA-seq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763047,"Cytokines,Forskoline,Mammo",NA,fastq,NTAP,NF0012,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Male,Homo sapiens,NF0012-3-6-M+C,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763054,NF0009-1--M-plus-C-plus-F_S35_L002_R1_001.fastq.gz,EpigeneticsAssayTemplate,e734fa8c-165a-4b16-a006-f29fc92e0285,59,NA,NA,RNA-seq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763054,"Cytokines,Forskoline,Mammo",NA,fastq,NTAP,NF0012,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Male,Homo sapiens,NF0012-3-6-M+C+F,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763065,NF0009-1--S-plus-C-plus-F_S41_L003_R2_001.fastq.gz,EpigeneticsAssayTemplate,c6ceaadf-c207-4907-ab66-79d560ed43f5,59,NA,NA,RNA-seq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763065,"Cytokines,Forskoline,StemPro",NA,fastq,NTAP,NF0012,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Male,Homo sapiens,NF0012-3-6-S+C,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763070,NF0009-1--M-plus-C_S34_L002_R2_001.fastq.gz,EpigeneticsAssayTemplate,0eaacf54-5dbf-4b69-a6b3-79bd30c7cb99,59,NA,NA,RNA-seq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763070,"Cytokines,Mammo",NA,fastq,NTAP,NF0012,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Male,Homo sapiens,NF0012-3-6-S+C+F,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763071,NF0009-1--M-plus-C_S34_L002_R1_001.fastq.gz,EpigeneticsAssayTemplate,8a8c422d-81aa-4fc7-8298-641a832cb67c,54,NA,NA,RNA-seq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763071,"Cytokines,Mammo",NA,fastq,NTAP,NF0002,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0002-8-19,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763072,NF0009-1--S-plus-C-plus-F_S41_L003_R1_001.fastq.gz,EpigeneticsAssayTemplate,ea78a196-1d4f-4539-8463-e7a146107773,54,NA,NA,RNA-seq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763072,"Cytokines,Forskoline,StemPro",NA,fastq,NTAP,NF0002,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0002-8-19 D,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763108,NF0009-1--S-plus-C_S40_L002_R1_001.fastq.gz,EpigeneticsAssayTemplate,c9fd5c0b-bc2d-4ddb-ab3b-c2790757cacc,54,NA,NA,RNA-seq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763108,"Cytokines,StemPro",NA,fastq,NTAP,NF0002,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0002-8-19 M,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763125,NF0009-1--S-plus-C_S40_L002_R2_001.fastq.gz,EpigeneticsAssayTemplate,8c3a6085-f57f-43e5-b7ac-bdbe572d3747,54,NA,NA,RNA-seq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763125,"Cytokines,StemPro",NA,fastq,NTAP,NF0002,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0002-8-19 S,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763134,NF0009-1_S4_L001_R2_001.fastq.gz,EpigeneticsAssayTemplate,2cb1d5cd-310c-4a39-809a-0b307bba20f3,54,NA,NA,RNA-seq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763134,NA,NA,fastq,NTAP,NF0002,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0002-8-19-D+C,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763142,NF0009-1_S4_L001_R1_001.fastq.gz,EpigeneticsAssayTemplate,7a649456-d025-41cd-82b8-ef8b36d8645f,54,NA,NA,RNA-seq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763142,NA,NA,fastq,NTAP,NF0002,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0002-8-19-D+C+F,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763143,NF0009-1--S--StemPro_S39_L002_R1_001.fastq.gz,EpigeneticsAssayTemplate,81ee07b8-da6e-40c4-940f-86025cde9bbf,54,NA,NA,RNA-seq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763143,NA,NA,fastq,NTAP,NF0002,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0002-8-19-M+C,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763147,NF0012-3-6--D--DMEM_S27_L002_R2_001.fastq.gz,EpigeneticsAssayTemplate,697496eb-7c35-4152-b1a7-63bc1150893a,54,NA,NA,RNA-seq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763147,DMEM,NA,fastq,NTAP,NF0002,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0002-8-19-M+C+F,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763148,NF0009-1--S--StemPro_S39_L002_R2_001.fastq.gz,EpigeneticsAssayTemplate,6fc0eeee-3dbe-4a7b-9d71-3d2b81623b79,54,NA,NA,RNA-seq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763148,NA,NA,fastq,NTAP,NF0002,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0002-8-19-S+C,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763154,NF0012-3-6--D--DMEM_S27_L002_R1_001.fastq.gz,EpigeneticsAssayTemplate,e9ead4df-ffae-4547-a3e4-a891faf27fc1,54,NA,NA,RNA-seq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763154,DMEM,NA,fastq,NTAP,NF0002,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0002-8-19-S+C+F,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763170,NF0012-3-6--D-plus-C-plus-F_S29_L002_R1_001.fastq.gz,EpigeneticsAssayTemplate,80fbdc5b-6a95-4436-a3f6-e68625a17878,39,NA,NA,rnaSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763170,"Cytokines,DMEM,Forskoline",NA,fastq,NTAP,NF0008,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0008-1,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763187,NF0012-3-6--D-plus-C-plus-F_S29_L002_R2_001.fastq.gz,EpigeneticsAssayTemplate,0bb84d2f-bba6-4f4c-bc5c-89debc7eb623,39,NA,NA,rnaSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763187,"Cytokines,DMEM,Forskoline",NA,fastq,NTAP,NF0008,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0008-1 D,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763196,NF0012-3-6--M-Mammo_S24_L002_R1_001.fastq.gz,EpigeneticsAssayTemplate,3871ad40-8cfa-4bef-9794-d53dba59f1ff,39,NA,NA,rnaSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763196,Mammo,NA,fastq,NTAP,NF0008,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0008-1-D+C+F,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763197,NF0012-3-6--M-Mammo_S24_L002_R2_001.fastq.gz,EpigeneticsAssayTemplate,7ea22342-551f-438e-89ff-f1124ae7698d,39,NA,NA,rnaSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763197,Mammo,NA,fastq,NTAP,NF0008,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0008-1-D+C,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763199,NF0012-3-6--D-plus-C_S28_L002_R1_001.fastq.gz,EpigeneticsAssayTemplate,23c6dcde-a79c-43c7-b0da-8e5e8b3f4bde,39,NA,NA,rnaSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763199,"Cytokines,DMEM",NA,fastq,NTAP,NF0008,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0008-1-S+C,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763201,NF0012-3-6--M-plus-C-plus-F_S26_L002_R1_001.fastq.gz,EpigeneticsAssayTemplate,7e3b6bcd-e782-46c0-9c36-6113535bd5e5,39,NA,NA,rnaSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763201,"Cytokines,Forskoline,Mammo",NA,fastq,NTAP,NF0008,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0008-1 S,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763202,NF0012-3-6--M-plus-C-plus-F_S26_L002_R2_001.fastq.gz,EpigeneticsAssayTemplate,ed40f702-0da7-4ec9-810e-d4d0a34fe05a,39,NA,NA,rnaSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763202,"Cytokines,Forskoline,Mammo",NA,fastq,NTAP,NF0008,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0008-1 M,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763205,NF0012-3-6--M-plus-C_S25_L002_R1_001.fastq.gz,EpigeneticsAssayTemplate,33f87265-d0c5-428e-8575-0aad028c1504,39,NA,NA,rnaSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763205,"Cytokines,Mammo",NA,fastq,NTAP,NF0008,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0008-1-S+C+F,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763209,NF0012-3-6--D-plus-C_S28_L002_R2_001.fastq.gz,EpigeneticsAssayTemplate,95d66bfd-4a97-4026-b1d0-114f5a6b3768,39,NA,NA,rnaSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763209,"Cytokines,DMEM",NA,fastq,NTAP,NF0008,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0008-1-M+C,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763217,NF0012-3-6--M-plus-C_S25_L002_R2_001.fastq.gz,EpigeneticsAssayTemplate,df409cdb-b25b-4acf-931e-64c58913860e,39,NA,NA,rnaSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763217,"Cytokines,Mammo",NA,fastq,NTAP,NF0008,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0008-1-M+C+F,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763229,NF0012-3-6--S--StemPro_S30_L002_R2_001.fastq.gz,EpigeneticsAssayTemplate,aaf4dafe-59a8-4b59-bd37-96fb9b509676,41,NA,NA,rnaSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763229,StemPro,NA,fastq,NTAP,NF0007,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0007-2,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763232,NF0012-3-6--S--StemPro_S30_L002_R1_001.fastq.gz,EpigeneticsAssayTemplate,77f5742e-953f-496f-8c99-e1064305f060,41,NA,NA,rnaSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763232,StemPro,NA,fastq,NTAP,NF0007,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0007-2 D,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763256,NF0012-3-6--S-plus-C_S31_L002_R2_001.fastq.gz,EpigeneticsAssayTemplate,7c8c0455-b3a2-49d1-ba6b-a80cb6e063c3,41,NA,NA,rnaSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763256,"Cytokines,StemPro",NA,fastq,NTAP,NF0007,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0007-2 M,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763261,NF0012-3-6_S3_L001_R1_001.fastq.gz,EpigeneticsAssayTemplate,9bb85ced-b064-43cb-8941-add026f2dca4,41,NA,NA,rnaSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763261,NA,NA,fastq,NTAP,NF0007,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0007-2 S,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763271,NF0012-3-6--S-plus-C_S31_L002_R1_001.fastq.gz,EpigeneticsAssayTemplate,39fbfb53-43b7-4d11-aa68-19d9708114d9,41,NA,NA,rnaSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763271,"Cytokines,StemPro",NA,fastq,NTAP,NF0007,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0007-2-D+C,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763273,NF0012-3-6_S3_L001_R2_001.fastq.gz,EpigeneticsAssayTemplate,26600a6c-e5b6-4166-b802-eb010268ac3e,41,NA,NA,rnaSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763273,NA,NA,fastq,NTAP,NF0007,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0007-2-D+C+F,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763516,NF0012-3-6--S-plus-C-plus-F_S32_L002_R2_001.fastq.gz,EpigeneticsAssayTemplate,cd4f0784-ca23-4d88-9f73-912bab4fa59d,41,NA,NA,rnaSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763516,"Cytokines,Forskoline,StemPro",NA,fastq,NTAP,NF0007,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,2,experimentalData,Female,Homo sapiens,NF0007-2-S+C,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
syn22763523,NF0012-3-6--S-plus-C-plus-F_S32_L002_R1_001.fastq.gz,EpigeneticsAssayTemplate,42541acd-821e-4506-bcbd-f3b74d0c6bb0,41,NA,NA,rnaSeq,NA,NA,raw,chromatinActivity,Neurofibromatosis type 1,NA,syn22763523,"Cytokines,Forskoline,StemPro",NA,fastq,NTAP,NF0007,Cutaneous Neurofibroma Initiative,No,No,No,NA,NA,NA,NA,-/-,+/+,NA,skin,NA,Illumina NovaSeq 6000,4,1,experimentalData,Female,Homo sapiens,NF0007-2-S+C+F,NA,syn11374354,A 3D Cutaneous Neurofibroma Model for Automated High-Throughput Drug Screenings,NA,NA,Cutaneous Neurofibroma
